ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,693Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 625

$1M Total Retail Price of All Prescriptions

Rank: 23 out of 625

689 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 689 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 689 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 13,196 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 614 543 1 1
LISINOPRIL 553 455 2 5
LEVOTHYROXINE SODIUM 462 401 3 3
FUROSEMIDE 396 337 4 7
ATORVASTATIN CALCIUM 351 312 5 9
METOPROLOL TARTRATE 349 289 6 11
SIMVASTATIN 335 287 7 2
OMEPRAZOLE 323 259 8 6
TRAMADOL HCL 316 272 9 16
METFORMIN HCL 306 256 10 10
HYDROCHLOROTHIAZIDE 261 238 11 12
HYDROCODONE-ACETAMINOPHEN 244 171 S3 12 4
WARFARIN SODIUM 243 220 13 20
POTASSIUM CHLORIDE 207 184 14 19
DONEPEZIL HCL 175 175 15 33
LANTUS 167 114 16 54
CARVEDILOL 157 147 17 23
ZOLPIDEM TARTRATE 154 141 18 13
PRAVASTATIN SODIUM 154 117 18 8
NAMENDA 149 149 20 45
DIGOXIN 143 134 21 55
CLONIDINE HCL 143 131 21 50
DIOVAN 137 127 23 28
CRESTOR 137 87 23 17
CLOPIDOGREL 128 118 25 30
ISOSORBIDE MONONITRATE ER 127 116 26 49
ESCITALOPRAM OXALATE 125 100 27 67
AMLODIPINE BESYLATE-BENAZEPRIL 125 118 27 48
GABAPENTIN 123 99 29 14
NOVOLIN R 121 109 30 223
ALLOPURINOL 119 114 31 29
METOPROLOL SUCCINATE 118 104 32 15
EXELON 113 113 33 129
NEXIUM 113 84 33 21
KLOR-CON M20 110 88 35 47
RISPERIDONE 108 75 36 92
CITALOPRAM HBR 108 104 36 24
ACTOS 105 86 38 102
GLIPIZIDE 103 103 39 56
PREDNISONE 100 97 40 37
CLOTRIMAZOLE-BETAMETHASONE 95 79 41 184
FLUTICASONE PROPIONATE 94 61 42 32
POLYETHYLENE GLYCOL 3350 91 76 43 82
TAMSULOSIN HCL 91 82 43 36
DICLOFENAC SODIUM 89 82 45 108
DIOVAN HCT 87 77 46 52
PLAVIX 86 77 47 43
CIPROFLOXACIN HCL 83 78 48 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 39 49 27
PHENYTOIN SODIUM EXTENDED 79 54 50 119
MIRTAZAPINE 78 63 51 69
NAPROXEN 78 65 51 104
MELOXICAM 76 69 53 31
NOVOLIN 70-30 75 75 54 154
LANSOPRAZOLE 75 66 54 159
EXFORGE 75 63 54 152
ATENOLOL 75 72 54 22
SYNTHROID 74 70 58 39
FENTANYL 73 67 S2 59 110
CYMBALTA 73 55 59 46
TRAZODONE HCL 72 57 61 51
LEVETIRACETAM 72 60 61 98
SPIRIVA 71 64 63 70
ADVAIR DISKUS 68 57 64 63
BENAZEPRIL HCL 67 54 65 35
AMOX TR-POTASSIUM CLAVULANATE 66 55 66 135
LOVASTATIN 64 64 67 58
LOSARTAN POTASSIUM 63 62 68 18
RANITIDINE HCL 62 50 69 25
IPRATROPIUM-ALBUTEROL 61 60 70 160
PANTOPRAZOLE SODIUM 61 59 70 44
LIPITOR 59 57 72 75
GLIMEPIRIDE 59 39 72 42
ALENDRONATE SODIUM 59 58 72 34
MEGESTROL ACETATE 56 53 R 75 183
PHENYTOIN 54 54 76 297
QUETIAPINE FUMARATE 53 36 77 106
PAROXETINE HCL 53 50 77 76
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 43 79 116
MOMETASONE FUROATE 52 42 79 293
TORSEMIDE 50 46 81 99
NIASPAN 50 43 81 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.